Results 41 to 50 of about 898,322 (221)
Fecal microbiota transplantation (FMT) is a promising strategy in the management of inflammatory bowel disease (IBD). The clinical effects of this practice are still largely unknown and unpredictable.
all the other FMT OPBG Committee Collaborators +11 more
core +1 more source
This study identifies GAP2, a bioactive polysaccharide fraction derived from Ganoderma applanatum, as a postbiotic inducer that repairs intestinal barrier damage in a gut microbiota‐dependent manner. GAP2 enriches Phocaeicola vulgatus, which degrades GAP2 and promotes tridecylic acid production, triggering Rho/CDC42 signaling and tight‐junction ...
Chuan Zhang +10 more
wiley +1 more source
Kurarinone ameliorates EAE via the gut microbiota‐indole‐3‐acetaldehyde‐AhR axis. Kurarinone reshapes gut microbiota and increases Akkermansia muciniphila, which promotes intestinal indole‐3‐acetaldehyde production. Indole‐3‐acetaldehyde crosses the intestinal barrier, activates AhR in CD4+ T cells, upregulates SOCS1/3, inhibits JAK2 and STAT3/4 ...
Xinyan Han +11 more
wiley +1 more source
Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results. [PDF]
Fecal microbiota transplantation (FMT) is a highly effective therapy for recurrent Clostridium difficile infection (R-CDI). Despite its excellent efficacy, it is still not a routine procedure in most European centers.
Vázquez-Cuesta, S +7 more
core +1 more source
This study reveals that Bacteroides fragilis drives depression in IBS‐D patients by producing ceramide‐1‐phosphate (C1P), which inhibits hippocampal SMPD4 and disrupts myelin integrity. Translationally, dietary branched‐chain amino acid restriction or SMPD4 restoration rescues this demyelination and depressive behavior, highlighting a novel gut–brain ...
Ping Zheng +12 more
wiley +1 more source
Several studies have confirmed that the pathophysiological progression of Alzheimer’s disease (AD) is closely related to changes in the intestinal microbiota; thus, modifying the intestinal microbiota has emerged as a new way to treat AD. Effective
Huan Yang +5 more
core +1 more source
Fecal microbiota transplantation in the obesity treatment – a literature review [PDF]
Introduction The World Health Organization (WHO) recognizes obesity as one of the ten most important threats affecting human health. The occurrence of obesity has been found to be closely linked to the phenomenon of intestinal dysbiosis.
LUCHOWSKA, Anna +5 more
core +1 more source
Sesamin reshapes the diabetic gut microbiota and increases microbiota‐associated indole‐3‐carboxaldehyde availability. ICA activates intestinal AhR signaling, enhances AhR occupancy at the Gcg promoter, and promotes GLP‐1 production. GLP‐1R signaling contributes to improved glucose tolerance and early insulin responses, linking microbial metabolism to ...
Zhichao Li +13 more
wiley +1 more source
Colonic in situ microbiota differ markedly from fecal microbiota in children with autism spectrum disorder and show stronger links with clinical severity. Washed microbiota transplantation remodels this intestinal microbial compartment toward donor‐like profiles, while models combining colonic microbiota and clinical features improve prediction of ...
Hong‐Qian Liu +10 more
wiley +1 more source

